Skip to main content
. 2023 May 16;13:1186503. doi: 10.3389/fonc.2023.1186503

Table 3.

Univariate and Multivariable Cox Regression Models for risk factors for Day 60 severe AKI.

Covariate Categories HR (95% CI) P aHR (95% CI) P
Age (years) – per one-year increase
1.0 (0.99-1.02) .53 1.00 (0.98-1.02) .95
Sex
Female 1 1
Male 0.58 (0.36-0.93) .02 0.66 (0.37-1.16) .15
Conditioning regimen
MAC 1
NAC 0.53 (0.21-1.32) .17
Baseline creatinine – per 1 Unit increase
0.9 (0.37-2.18) .82
Acute GVHD
Grade 0-1 1 1
Grade 2-4 0.54 (0.3-0.96) .04 0.53 (0.26-1.10) .09
Acute Skin GVHD
Grade 0-1 1
Grade 2-4 0.65 (0.36-1.18) .16
Acute Liver GVHD
Grade 0-1 1
Grade 2-4 2.73 (1.17-6.4) .02
Acute Gut GVHD
Grade 0-1 1
Grade 2-4 0.65 (0.23-1.8) 0.4
Systemic steroid administration
0.36 (0.18-0.72) .004
Vancomycin administration
0.23 (0.06-0.95) .04
Gentamycin administration
2.1 (0.5-8.85) .31
Cyclosporine – per 100 Unit increase
1.19 (1.03-1.37) .02 1.18 (1.02-1.37) .02
Tacrolimus – per 1 Unit increase
1.21 (0.9-1.62) .2
Bilirubin – per 1 Unit increase
1.3 (1.18-1.43) <.0001 1.23 (1.13-1.34) <.0001
Log(CMV) – per 1 Unit increase
1.37 (1.07-1.76) .01 1.35 (0.98-1.85) .06
Log(BK) – per 1 Unit increase
0.58 (0.32-1.05) .07

AKI, acute kidney injury; HR, Hazard Ratio; aHR, adjusted HR; NAC, non-myeloablative conditioning; MAC, myeloablative conditioning; GVHD, graft versus host disease; CMV, cytomegalovirus.

Amphotericin administration was not considered in this model due to the limited number of patients.

These variables were modeled as time-dependent indicator variables.

These variables were modeled as time- dependent continuous linear variables.